Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | September 1, 2006 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00392444 |
| Study Type: | Interventional |
| Intervention: | Drug: sunitinib malate |
| Study Design: | Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | NCIC Clinical Trials Group|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 39 |
| Funded By: | Other|NIH |
| First Received: | October 25, 2006 |
| End Date: | |
| Last Updated: | November 7, 2010 |
| Last Verified: | September 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
